CHINATRIALS 5 ADVISORY BOARD

Menghis Bairu, M.D. Executive Vice President & General Manager ELAN PHARMACEUTICALS	James Garner, M.D. Vice President & General Manager TAKEDA GLOBAL R&D CENTER ASIA	Min Irwin, M.D., Ph.D. Medical Director of BSP BAYER HEALTHCARE

Ming Ji, M.D., Ph.D. Senior Medical Director, Clinical Safety Evaluation/Global Pharmacovigilance ABBOTT LABORATORIES	Frank Jiang, M.D., Ph.D. Vice President, Global R&D/Head, China R&D SANOFI	Nadina Jose, M.D. Managing Director ANIDAN GROUP

Simon Li, M.D., Ph.D Global Clinical Leader, PC BAYER HEALTHCARE	Qing Li, M.D., Ph.D. Senior Director, OTC R&D XIAN-JANSSEN PHARMACEUTICAL	Sally Sha Business Development Director & Project Director TIGERMED

Jingsong Wang, M.D. Head of China R&D SANOFI	William Wang, Ph.D. Head, Asia Pacific Operations, BARDS MERCK & CO.	Zaiqi Wang, M.D., Ph.D. Director of Clinical Research MSD CHINA

Dan Zhang Chief Executive Officer FOUNTAIN MEDICAL DEVELOPMENT

About Your Organizer

Jon E. Liong, Managing Partner, LYCHEE GROUP
Jon brings 10 years of success in the strategic planning, organization and marketing of over 100 pharmaceutical and biotech business-to-business conferences. He conceived and launched the "IMPACT CHINA: Pharmaceutical Global R&D" series, which was the first-ever global R&D event covering China's life sciences industry. The meeting helped foster early collaborations between Western companies and all aspects of China's nascent pharmaceutical industry.